![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1996-3181|7|3|313-320
ISSN: 1871-5273
Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.3, 2008-06, pp. : 313-320
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegeneration in multiple sclerosis
PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Timmermans Silke Bogie Jeroen Vanmierlo Tim Lütjohann Dieter Stinissen Piet Hellings Niels Hendriks Jerome
Journal of Neuroimmune Pharmacology, Vol. 9, Iss. 2, 2014-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Animal models of multiple sclerosis
PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. :